Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Manuela, Fantini"'
Autor:
Alberto Bongiovanni, Flavia Foca, Manuela Fantini, Maria Rosachiara Forcignanò, Fabrizio Artioli, Rossana Berardi, Enrico Campadelli, Giuseppe Procopio, Francesco Silvestris, Nada Riva, Lorena Gurrieri, Silvia Angela Debonis, Giandomenico Di Menna, Valentina Fausti, Federica Recine, Roberto Vespignani, Toni Ibrahim
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social and healthcare costs. At present, data available on B
Externí odkaz:
https://doaj.org/article/693a0fc1e87149f99ffcaa4f3dfc147a
Autor:
Alberto Bongiovanni, Flavia Foca, Jessica Menis, Stefania Luigia Stucci, Fabrizio Artioli, Valentina Guadalupi, Maria Rosachiara Forcignanò, Manuela Fantini, Federica Recine, Laura Mercatali, Chiara Spadazzi, Marco Angelo Burgio, Valentina Fausti, Anna Miserocchi, Toni Ibrahim
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
IntroductionBone metastases (BMs) are a negative prognostic factor in patients with non-small cell lung cancer (NSCLC). Although immune-checkpoint inhibitors (ICIs) have dramatically changed the therapeutic landscape of NSCLC, little information is a
Externí odkaz:
https://doaj.org/article/efaf44bda0a24525b2e67623d8a9d899
Autor:
Flavia Foca, Lorena Gurrieri, Federica Recine, Alberto Bongiovanni, Roberto Vespignani, Nada Riva, Giuseppe Procopio, Manuela Fantini, Maria Rosachiara Forcignanò, Francesco Silvestris, Giandomenico Di Menna, Toni Ibrahim, Rossana Berardi, Silvia Angela Debonis, Fabrizio Artioli, Valentina Fausti, Enrico Campadelli
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports
Scientific Reports
Bone metastases (BM) are still the main cause of morbidity in cancer patients because of skeletal-related events (SREs) that reduce quality of life. They have also led to increased social and healthcare costs. At present, data available on BM are ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce5a34f25f0f7d9c39112b971edc67fe
https://doi.org/10.1038/s41598-021-83749-1
https://doi.org/10.1038/s41598-021-83749-1
Autor:
Toni Ibrahim, Silvia Vanni, Laura Mercatali, Jessica Menis, M.C. Pallotti, Valentina Fausti, M.R.C. Forcignanò, Flavia Foca, Chiara Spadazzi, M.C. Falasconi, M. Bertoni, Roberto Casadei, L.S. Stucci, Federica Recine, A. De Vita, Alberto Bongiovanni, Manuela Fantini, Fabrizio Artioli, V. Guadalupi
Publikováno v:
Annals of Oncology. 32:S1004-S1005
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebd19a12e25a6e7f02a314dbf4d598fa
https://doi.org/10.1016/j.annonc.2021.08.1898
https://doi.org/10.1016/j.annonc.2021.08.1898
Autor:
Francesco Montanari, Emiliano Tamburini, Sergio Sartori, Britt Roudnas, Emanuela Bianchi, Davide Tassinari, Chiara Cherubini, Manuela Fantini, Fabrizio Drudi
Publikováno v:
Reviews on Recent Clinical Trials. 13:226-237
Introduction To compare the efficacy of abiraterone acetate, enzalutamide, cabazitaxel and Radium-223 in the treatment of castration-resistant, docetaxel-resistant metastatic prostate cancer. Methods An indirect comparison of Overall Survival (OS) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e3481d7acefbe0892467c1b24cffd32
https://doi.org/10.2174/1574887113666180404120540
https://doi.org/10.2174/1574887113666180404120540
Publikováno v:
International Journal of Immunopathology and Pharmacology. 29:494-497
Adjuvant therapy in postmenopausal women with endocrine-responsive breast cancer (BC) is actually centered on the use of anti-aromatase inhibitors (AI). Several reports, however, are emerging in literature associating the use of this drugs to rheumat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dc18ab2a6c65507bef1f09aec72f47c
https://doi.org/10.1177/0394632016651086
https://doi.org/10.1177/0394632016651086
Autor:
Laura Mercatali, Chiara Spadazzi, Manuela Fantini, Valentina Fausti, Jessica Menis, Francesco Silvestris, Giandomenico Di Menna, Roberto Vespignani, Toni Ibrahim, Rossana Berardi, R. Forcignanò, Flavia Foca, Silvia Angela Debonis, Federica Recine, Banca Dati Metastasi Ossee Study Team, Nada Riva, Giuseppe Procopio, Alberto Bongiovanni, Fabrizio Artioli, Enrico Campadelli, Lorena Gurrieri
Publikováno v:
Journal of Clinical Oncology. 38:e13072-e13072
e13072 Background: Bone Metastases (BM) are still the main cause of morbidity and morbility in cancer patients because of their complications defined as skeletal-related events (SREs).SREs reduce pts quality of life and are associated with an increas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aba44c845eafc62cd360e62b288d8936
https://doi.org/10.1200/jco.2020.38.15_suppl.e13072
https://doi.org/10.1200/jco.2020.38.15_suppl.e13072
Autor:
Maximilian Papi, Luigi Lazzari-Agli, Sergio Sartori, Fabrizio Drudi, Manuela Fantini, Davide Tassinari, Emiliano Tamburini, Chiara Cherubini
Publikováno v:
Journal of chemotherapy (Florence, Italy). 29(6)
An indirect comparison of cisplatin-pemetrexed (CP) and cisplatin-raltitrexed (CR) was performed. The Odds Ratios of 10, 15 and 20 month survival rate and response rate were assumed as indexes of efficacy; the Odds Ratio of grade III-IV side effects,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1cbb98093551a0e6467e82cd082d08e
https://pubmed.ncbi.nlm.nih.gov/28697647
https://pubmed.ncbi.nlm.nih.gov/28697647
Autor:
Francesco Montanari, Manuela Fantini, Emiliano Tamburini, Carlotta Santelmo, Fabrizio Drudi, Sergio Sartori, L. Stocchi, Lorenzo Gianni, Davide Tassinari
Publikováno v:
Reviews on recent clinical trials. 11(4)
Background: To assess the role of docetaxel plus androgen deprivation in metastatic, hormone- sensitive prostate cancer. Methods: A qualitative systematic review of literature was performed. All the randomized phase III trials comparing docetaxel plu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0d84bd9344856590d6570ee3e39631
https://pubmed.ncbi.nlm.nih.gov/27448518
https://pubmed.ncbi.nlm.nih.gov/27448518
Autor:
Lorenzo Gianni, Claudio Ridolfi, Alessandra Affatato, Eleonora Barzotti, Fabrizio Drudi, Carlotta Santelmo, Alberto Ravaioli, Valentina Arcangeli, Manuela Fantini
Publikováno v:
Journal of Cancer Therapy. :777-781
Triple negative breast cancer (TNBC) is characterized by a high sensitivity to antiblastic drugs and a high pathological complete remission rate after neoadjuvant therapy. In patients showing complete remission, the probability of developing metastat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c218dfd357b657592229c90ea0ee435c
https://doi.org/10.4236/jct.2012.325097
https://doi.org/10.4236/jct.2012.325097